Hydroxychloroquine placebo

DRUG4 trials

Sponsors

Washington University School of Medicine, Rigshospitalet, Denmark, Assistance Publique - Hôpitaux de Paris, LAGOS STATE GOVERNMENT

Conditions

Covid-19Recurrent Pregnancy LossSARS-CoV-2 InfectionType 2 Diabetes Mellitus

Phase 3

Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

Rigshospitalet, DenmarkRecurrent Pregnancy Loss

Start: 2018-01-25End: 2023-01-31Target: 186Updated: 2020-03-12

Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)

Active, not recruitingPACTR202004801273802

LAGOS STATE GOVERNMENTCovid-19

Start: 2020-04-20Target: 800Updated: 2026-01-27

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus

CompletedNCT04344379

Assistance Publique - Hôpitaux de ParisSARS-CoV-2 Infection

Start: 2020-04-17End: 2020-06-18Updated: 2025-11-20

Unknown Phase

Metabolic Effects of Hydroxychloroquine

TerminatedNCT02026232

Washington University School of MedicineType 2 Diabetes Mellitus

Start: 2012-03-31End: 2022-12-15Updated: 2023-12-28

Related Papers

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial

Trials2021-12-013 citations